UNSPSC 51142300: Narcotic antagonists

This classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.

UNSPSC 51142300 Narcotic antagonists is a Class code covering naloxone products in multiple formulations — intranasal sprays, prefilled syringes with and without attached needles, auto-injectors, and vials — that state and local governments procure to support overdose prevention and emergency response programs. State health and human services departments and county health authorities are the primary issuing bodies, soliciting supply contracts to stock community health facilities, authorized distributors, and emergency response networks with ready-to-deploy antagonist inventory. The work involves manufacturing and supply-chain capability rather than professional services; respondents must demonstrate the ability to deliver high volumes to dispersed networks on short schedules, often with no ramp-up period and same-day or overnight emergency delivery at no additional cost.

Recent activity concentrates in Florida, with the State of Florida Department of Children and Families (Substance Abuse and Mental Health division) issuing RFP 16548 for emergency opioid antagonist products with multiple formulations in various strengths, educational materials in English, Spanish, and Haitian Creole, USA manufacturing requirement, and 30-month minimum shelf-life. The RFP (posted July 27, 2026, with response deadline updated multiple times through September addenda, most recently November 10, 2026) requires selected vendors to deliver to approximately 1,500 authorized distributors statewide with two-day standard shipping and no-cost overnight emergency delivery Monday–Friday; vendors proposing 4mg products must demonstrate documented history shipping at least 65,000 units to over 1,300 distributors within a single month for at least ten months per year and 150,000 units within a single month for at least two months per year. Contract term runs one year from November 20, 2026 through November 19, 2027 with potential renewal for up to three additional years. Seminole County, Florida also issued IFB 60459723LAS (posted June 30, 2026) for 1,900 naloxone units and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, two-year initial term with one-year renewal option, and fixed-fee pricing structure.